2023DolutegravirODYSSEY TrialStudiesNeuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trialREAD MORE
2023DolutegravirODYSSEY TrialStudiesEffect of dolutegravir on folate, vitamin B12 and mean corpuscular volume levels among children and adolescents with HIV: a sub-study of the ODYSSEY randomized controlled trialREAD MORE
2022DolutegravirStudiesPrevalence of neuropsychiatric adverse events and associated factors among adult patients on dolutegravir attending Mulago ISS clinicREAD MORE
